Arthritis Drug Might be the Answer to Severe, Stubborn Eczema
Researchers at Yale School of Medicine have beat previously untreatable eczema with an arthritis drug. The Yale researchers have successfully treated patients using a drug designed for the treatment rheumatoid arthritis. The same drug was recently used to treat and reverse two other disfiguring skin conditions, alopecia areata and vitiligo.
The drug is called Tofacitinib Citrate. It was used in the treatment of six patients, all of whom reported a significant reduction in itch and also improved sleep. Other symptoms, like redness of the skin, also diminished.
Individuals reported that they were very happy with the results, and were relieved by renewed skin comfort.
Researchers are hopeful that we are entering a whole new level of eczema treatment. New studies like this one are suggesting large changes to the standard of care that eczema patients receive, as well as more research, development, and findings.